-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BgTo3sGOKaopaY6r6D9MboWt0H3iqVbTi7qaXqnbdwh8IhYJEikvQXhEisUwsfms qvF13RdLNW+ZZJovAnFmrg== 0000950144-08-004217.txt : 20080516 0000950144-08-004217.hdr.sgml : 20080516 20080516172238 ACCESSION NUMBER: 0000950144-08-004217 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080514 ITEM INFORMATION: Other Events FILED AS OF DATE: 20080516 DATE AS OF CHANGE: 20080516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MEDICAL PROPERTIES TRUST INC CENTRAL INDEX KEY: 0001287865 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-32559 FILM NUMBER: 08843308 BUSINESS ADDRESS: STREET 1: 1000 UBRAN CENTER DRIVE STREET 2: SUITE 501 CITY: BIRMINGHAM STATE: AL ZIP: 35242 BUSINESS PHONE: 205-969-3755 MAIL ADDRESS: STREET 1: 1000 URBAN CENTER DRIVE STREET 2: SUITE 501 CITY: BIRMINGHAM STATE: AL ZIP: 35242 8-K 1 g13543e8vk.htm MEDICAL PROPERTIES TRUST, INC. MEDCIAL PROPERTIES TRUST, INC.
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of report (Date of earliest event reported): May 14, 2008
MEDICAL PROPERTIES TRUST, INC.
(Exact Name of Registrant as Specified in Charter)
Commission File Number 001-32559
     
Maryland
(State or Other Jurisdiction
of Incorporation) 		  20-0191742
(IRS. Employer
Identification No.)
     
1000 Urban Center Drive, Suite 501
Birmingham, AL
(Address of principal executive offices) 		  35242
(Zip Code)
Registrant’s telephone number, including area code
(205) 969-3755
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 

 

Item 8.01. Other Events.
     On May 14, 2008, Edward K. Aldag, Jr., Chairman of the Board, President and Chief Executive Officer of Medical Properties Trust, Inc. (the “Company”), entered into a written stock selling plan (the “10b5-1 Plan”) in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended, and the Company’s Insider Trading Policy.
     Under Rule 10b5-1, directors, officers and other employees may adopt a pre-arranged plan or contract for the sale of Company securities under specified conditions and at specified times when they are not in possession of material non-public information. Using 10b5-1 plans, individuals can gradually diversify their investment portfolios, or raise funds for income tax obligations or other needs, by spreading stock trades out over an extended period of time so as to reduce market impact and avoid concerns about transactions occurring at a time when they might possess material non-public information.
     The 10b5-1 Plan entered into by Mr. Aldag allows for the sale of a maximum of approximately 186,000 shares of the Company’s common stock, par value $0.001 per share, over a six-month period beginning on May 22, 2008. Sales of shares by Mr. Aldag pursuant to the 10b5-1 Plan provide for sales of specified share amounts on the open market on specified dates at prevailing market prices. Such sales are being made by Mr. Aldag for income tax purposes and other financial planning needs.
     Transactions made under the 10b5-1 Plan will be disclosed publicly through Form 144 and Form 4 filings with the Securities and Exchange Commission. Except as may be required by law, the Company does not undertake to report on specific Rule 10b5-1 pre-planned stock trading plans of Company officers, nor to report modifications or terminations of the aforementioned 10b5-1 Plan or the plan of any other individual.

 

 

SIGNATURE
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  MEDICAL PROPERTIES TRUST, INC.
(Registrant)
 		  
  By:   /s/ R. Steven Hamner    
    R. Steven Hamner   
    Executive Vice President and Chief Financial Officer
(Principal Financial and Accounting Officer) 		  
 
Date:   May 16, 2008

 

-----END PRIVACY-ENHANCED MESSAGE-----